About
Acceptance Rate:
16%
Time to first decision with review:
43 days*
Impact Factor:
9.102
Impact Factor rank (JCR):
9/65
Citescore:
13.3
2021 total Altmetric mentions:
9,297
Aims and scope
Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, critical care, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice. This includes articles concerning basic and translational mechanisms with application to clinical material (cell and molecular biology, genetics, epidemiology, and immunology).
Thorax is BMJ's flagship respiratory medicine journal and has an open access companion journal, BMJ Open Respiratory Research.
For information about the Thorax editorial team and the joint Editors-in-Chief (Nicholas Hart, Gisli Jenkins and Alan Smyth), please refer to the Editorial Board page.
Plan S compliance
Thorax is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Journal information
Ownership
Thorax is co-owned by the British Thoracic Society and BMJ
Publication Model
Subscription; with hybrid open access option
Frequency
Monthly
Launch date
1946
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Expanded; BIOSIS Reviews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer review model
Single blind; the names of reviewers are hidden from the author
Print ISSN
0040-6376
Online ISSN
1468-3296
Journal Statistics (2020)
Acceptance rate: 16%
Speed
Time to first decision without review (median): 2 days
Time to first decision with review (median) : 43 days
Time from acceptance to publication (median): 21 days
Impact
Impact Factor category: Respiratory System
Impact Factor (JCR): 9.102
Impact Factor rank: 9/65
5 Year Impact Factor: 11.278
Journal Citation Indicator: 1.97
Eigenfactor Score: 0.02128
Citescore: 13.3
Citescore rank: 6/140
SciMago Journal Rank (SJR): 2.309
Reach
2021 total content views: 1.98m
2021 total Altmetric mentions: 9,297
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact information
For all contact information please refer to the Contact Us page.
For authors
Please refer to the Instructions for Authors.
Subscriptions
To advertise
Rights and permissions
Affiliations
Thorax is provided as a benefit to members of the British Thoracic Society (BTS).
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.